Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 33.16
+0.47 (1.44%)
At close: Jan 23, 2026
SHE:301166 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -19.01 | 10.15 | 40.32 | 106.6 | 108.73 | 76.49 | Upgrade |
Depreciation & Amortization | 21.15 | 21.15 | 18.88 | 11.67 | 6.65 | 6.22 | Upgrade |
Other Amortization | 4.71 | 4.71 | 2.77 | 1.08 | 0.64 | 0.53 | Upgrade |
Loss (Gain) From Sale of Assets | 0.91 | 0.91 | 0 | -0.03 | 0.24 | - | Upgrade |
Asset Writedown & Restructuring Costs | 0 | 0 | 0 | 0.02 | 0 | - | Upgrade |
Loss (Gain) From Sale of Investments | -29.45 | -29.45 | -30.03 | -22.61 | - | -0.7 | Upgrade |
Provision & Write-off of Bad Debts | 6.14 | 6.14 | 3.73 | 11.21 | 3 | 2.94 | Upgrade |
Other Operating Activities | -26.06 | 3.52 | 15.74 | 6.26 | 0.17 | -0.29 | Upgrade |
Change in Accounts Receivable | 24.79 | 24.79 | -11.31 | -159.35 | -56.97 | -30.1 | Upgrade |
Change in Inventory | 71.49 | 71.49 | -43.59 | -93.06 | -33.02 | -8.12 | Upgrade |
Change in Accounts Payable | -18.14 | -18.14 | 9.49 | 4.15 | 32.97 | 47.49 | Upgrade |
Change in Other Net Operating Assets | 0.12 | 0.12 | -3.38 | 3.38 | - | - | Upgrade |
Operating Cash Flow | 17.23 | 75.97 | -22.69 | -143.3 | 59.02 | 92.23 | Upgrade |
Operating Cash Flow Growth | -76.16% | - | - | - | -36.00% | 857.39% | Upgrade |
Capital Expenditures | -66.76 | -71.2 | -63.18 | -61.5 | -14.31 | -4.95 | Upgrade |
Sale of Property, Plant & Equipment | 0.03 | 0.02 | 0.11 | 0.11 | 0.11 | - | Upgrade |
Investment in Securities | -26.42 | 471.5 | -113.47 | -977.5 | - | 50 | Upgrade |
Other Investing Activities | 23.95 | 31.39 | 26.8 | 20.61 | - | 0.91 | Upgrade |
Investing Cash Flow | -69.21 | 431.71 | -149.74 | -1,018 | -14.2 | 45.96 | Upgrade |
Short-Term Debt Issued | - | - | - | 80 | - | 10 | Upgrade |
Long-Term Debt Issued | - | 0.01 | - | - | - | - | Upgrade |
Total Debt Issued | 0.01 | 0.01 | - | 80 | - | 10 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -10 | -46.7 | Upgrade |
Long-Term Debt Repaid | - | -8.92 | -88.9 | -5.42 | -2.18 | - | Upgrade |
Total Debt Repaid | -8.92 | -8.92 | -88.9 | -5.42 | -12.18 | -46.7 | Upgrade |
Net Debt Issued (Repaid) | -8.91 | -8.91 | -88.9 | 74.58 | -12.18 | -36.7 | Upgrade |
Issuance of Common Stock | - | - | - | - | 1,617 | - | Upgrade |
Repurchase of Common Stock | -19.5 | -19.5 | - | - | - | - | Upgrade |
Common Dividends Paid | -18.8 | -40.72 | -78.84 | -44.26 | -20.2 | -0.38 | Upgrade |
Dividends Paid | -18.8 | -40.72 | -78.84 | -44.26 | -20.2 | -0.38 | Upgrade |
Other Financing Activities | 6.38 | - | - | -11.15 | -6.8 | - | Upgrade |
Financing Cash Flow | -40.83 | -69.12 | -167.74 | 19.17 | 1,578 | -37.08 | Upgrade |
Foreign Exchange Rate Adjustments | -0.23 | 0.71 | 0.6 | 1.69 | -0.41 | 1.03 | Upgrade |
Net Cash Flow | -93.03 | 439.26 | -339.57 | -1,141 | 1,622 | 102.14 | Upgrade |
Free Cash Flow | -49.53 | 4.77 | -85.87 | -204.8 | 44.72 | 87.28 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -48.77% | 1995.74% | Upgrade |
Free Cash Flow Margin | -4.65% | 0.43% | -7.00% | -17.14% | 4.03% | 10.28% | Upgrade |
Free Cash Flow Per Share | -0.58 | 0.06 | -1.00 | -2.36 | 0.68 | 1.35 | Upgrade |
Cash Income Tax Paid | 33.25 | 46.06 | 43.53 | 42.82 | 70 | 47.08 | Upgrade |
Levered Free Cash Flow | -87.99 | -13.2 | -11.95 | -238.05 | 31.39 | 64.14 | Upgrade |
Unlevered Free Cash Flow | -87.34 | -12.55 | -10.67 | -237.24 | 31.46 | 64.38 | Upgrade |
Change in Working Capital | 58.84 | 58.84 | -74.1 | -257.51 | -60.41 | 7.04 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.